These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
412 related items for PubMed ID: 19269141
1. Emerging fluoroquinolone-non-susceptible group A streptococci in two different paediatric populations. Smeesters PR, Vergison A, Junior DC, Van Melderen L. Int J Antimicrob Agents; 2009 Jul; 34(1):44-9. PubMed ID: 19269141 [Abstract] [Full Text] [Related]
2. Emergence of high-level fluoroquinolone resistance in emm6 Streptococcus pyogenes and in vitro resistance selection with ciprofloxacin, levofloxacin and moxifloxacin. Malhotra-Kumar S, Van Heirstraeten L, Lammens C, Chapelle S, Goossens H. J Antimicrob Chemother; 2009 May; 63(5):886-94. PubMed ID: 19279051 [Abstract] [Full Text] [Related]
3. Increase in fluoroquinolone non-susceptibility among clinical Streptococcus pyogenes in Belgium during 2007-10. Van Heirstraeten L, Leten G, Lammens C, Goossens H, Malhotra-Kumar S. J Antimicrob Chemother; 2012 Nov; 67(11):2602-5. PubMed ID: 22815354 [Abstract] [Full Text] [Related]
4. In vitro induction and selection of fluoroquinolone-resistant mutants of Streptococcus pyogenes strains with multiple emm types. Billal DS, Fedorko DP, Yan SS, Hotomi M, Fujihara K, Nelson N, Yamanaka N. J Antimicrob Chemother; 2007 Jan; 59(1):28-34. PubMed ID: 17065188 [Abstract] [Full Text] [Related]
5. Intrinsic reduced susceptibility of serotype 6 Streptococcus pyogenes to fluoroquinolone antibiotics. Orscheln RC, Johnson DR, Olson SM, Presti RM, Martin JM, Kaplan EL, Storch GA. J Infect Dis; 2005 Apr 15; 191(8):1272-9. PubMed ID: 15776373 [Abstract] [Full Text] [Related]
7. Comparison of full gyrA, gyrB, parC and parE gene sequences between all Ureaplasma parvum and Ureaplasma urealyticum serovars to separate true fluoroquinolone antibiotic resistance mutations from non-resistance polymorphism. Beeton ML, Chalker VJ, Kotecha S, Spiller OB. J Antimicrob Chemother; 2009 Sep 15; 64(3):529-38. PubMed ID: 19567408 [Abstract] [Full Text] [Related]
8. Differences between Belgian and Brazilian group A Streptococcus epidemiologic landscape. Smeesters PR, Vergison A, Campos D, de Aguiar E, Miendje Deyi VY, Van Melderen L. PLoS One; 2006 Dec 20; 1(1):e10. PubMed ID: 17183632 [Abstract] [Full Text] [Related]
9. Macrolide resistance in Streptococcus pyogenes: prevalence, resistance determinants, and emm types. Michos AG, Bakoula CG, Braoudaki M, Koutouzi FI, Roma ES, Pangalis A, Nikolopoulou G, Kirikou E, Syriopoulou VP. Diagn Microbiol Infect Dis; 2009 Jul 20; 64(3):295-9. PubMed ID: 19395219 [Abstract] [Full Text] [Related]
11. Characterisation of fluoroquinolone-resistant clinical isolates of Streptococcus pyogenes in Barcelona, Spain. Rivera A, Rebollo M, Sánchez F, Navarro F, Miró E, Mirelis B, Coll P. Clin Microbiol Infect; 2005 Sep 20; 11(9):759-61. PubMed ID: 16104992 [Abstract] [Full Text] [Related]
12. Seven-year surveillance of north american pediatric group a streptococcal pharyngitis isolates. Shulman ST, Tanz RR, Dale JB, Beall B, Kabat W, Kabat K, Cederlund E, Patel D, Rippe J, Li Z, Sakota V, North American Streptococcal Pharyngitis Surveillance Group. Clin Infect Dis; 2009 Jul 01; 49(1):78-84. PubMed ID: 19480575 [Abstract] [Full Text] [Related]
13. Streptococcus pyogenes pharyngeal isolates with reduced susceptibility to ciprofloxacin in Spain: mechanisms of resistance and clonal diversity. Albertí S, Cortés G, García-Rey C, Rubio C, Baquero F, García-Rodríguez JA, Bouza E, Aguilar L. Antimicrob Agents Chemother; 2005 Jan 01; 49(1):418-20. PubMed ID: 15616324 [Abstract] [Full Text] [Related]
14. Distribution of emm types among group A streptococcal isolates from Serbia. Mijac V, Ranin L, Marković M, Heeg C, Reinert RR, Opavski N. Clin Microbiol Infect; 2010 Mar 01; 16(3):295-8. PubMed ID: 19519840 [Abstract] [Full Text] [Related]
15. Worldwide incidence, molecular epidemiology and mutations implicated in fluoroquinolone-resistant Streptococcus pneumoniae: data from the global PROTEKT surveillance programme. Canton R, Morosini M, Enright MC, Morrissey I. J Antimicrob Chemother; 2003 Dec 01; 52(6):944-52. PubMed ID: 14585861 [Abstract] [Full Text] [Related]
16. Genetic diversity of Group A Streptococcus M protein: implications for typing and vaccine development. Smeesters PR, Mardulyn P, Vergison A, Leplae R, Van Melderen L. Vaccine; 2008 Oct 29; 26(46):5835-42. PubMed ID: 18789365 [Abstract] [Full Text] [Related]
17. Emergence of fluoroquinolone-resistant Streptococcus pyogenes in Japan by a point mutation leading to a new amino acid substitution. Arai K, Hirakata Y, Yano H, Kanamori H, Endo S, Hirotani A, Abe Y, Nagasawa M, Kitagawa M, Aoyagi T, Hatta M, Yamada M, Nishimaki K, Takayama Y, Yamamoto N, Kunishima H, Kaku M. J Antimicrob Chemother; 2011 Mar 29; 66(3):494-8. PubMed ID: 21172783 [Abstract] [Full Text] [Related]
18. Associations of macrolide and fluoroquinolone resistance with molecular typing in Streptococcus pyogenes from invasive infections, 2010-2012. Wajima T, Morozumi M, Chiba N, Shouji M, Iwata S, Sakata H, Ubukata K. Int J Antimicrob Agents; 2013 Nov 29; 42(5):447-9. PubMed ID: 23988719 [Abstract] [Full Text] [Related]
19. Outbreak of invasive group A streptococcal disease among children attending a day-care center. Aguero J, Ortega-Mendi M, Eliecer Cano M, Gonzalez de Aledo A, Calvo J, Viloria L, Mellado P, Pelayo T, Fernandez-Rodriguez A, Martinez-Martinez L. Pediatr Infect Dis J; 2008 Jul 29; 27(7):602-4. PubMed ID: 18520444 [Abstract] [Full Text] [Related]
20. Decrease of erythromycin resistance in group A streptococci by change of emm distribution. Koh EH, Kim S, Lee NY. Jpn J Infect Dis; 2008 Jul 29; 61(4):261-3. PubMed ID: 18653965 [Abstract] [Full Text] [Related] Page: [Next] [New Search]